斯達外科手術 STAA 深 滬
等待開盤 01-29 09:30:00 美东时间
19.37
+0.330
+1.73%
華盛通- 最 高19.535
- 今 開18.94
- 成交量 52.12万股
- 最 低 18.94
- 昨 收 19.04
- 總市值 9.64亿
- 52周最高 30.81
- 市盈率 靜 --
- 換手率 1.05%
- 52周最低 13.50
- 委 比 -20.00%
- 總股本 4974.20万
- 歷史最高 163.08
- 量 比 0.51
- 振 幅 3.13%
- 歷史最低 4.48
- 每 手 1
- 風險率 4.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多STAAR Surgical Company Files Initial Beneficial Ownership Statement for Director Richard T. LeBuhn
STAAR Surgical Company Files Initial Beneficial Ownership Statement for Director Richard T. LeBuhn STAAR Surgical Company has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing identifies Richard T. LeBuhn as a beneficial owner in the role
01-24 06:14
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
Staar Surgical reshapes board under new investor agreement
The latest update is out from Staar Surgical ( ($STAA) ). On January 14–15, 202...
01-15 22:49
STAAR Surgical, Broadwood Partners Sign Deal To Appoint Neal C. Bradsher, Richard T. LeBuhn, Christopher Wang To STAAR's Board, Effective Immediately
STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, and Broadwood Partners,
01-15 21:32
Staar Surgical shareholders reject merger, company stays independent
Staar Surgical ( ($STAA) ) has shared an announcement. On August 4, 2025, STAAR...
01-07 06:19
STAAR Surgical to Terminate Alcon Merger, Stay Independent
An update from Staar Surgical ( ($STAA) ) is now available. On January 6, 2026,...
01-06 22:30
STAAR Surgical vote on Alcon may be delayed again - report
A STAAR Surgical (STAA) holder vote on Alcon's (ALC) planned purchase may be delayed as the companies are contractually obligated to delay while Alcon considers raising its offer again, according to a...
01-06 04:35
CyberArk/Palo Alto Networks, Dayforce/Thoma Bravo among good bets for deal close
Palo Alto Networks' (PANW) $25 billion purchase of CyberArk (CYBR) and Thoma Bravo's planned $12.3 billion acquisition of Dayforce are among the deals likely to close in the new year. "Thoma Bravo is...
2025-12-27 03:34
STAAR Surgical falls as proxy adviser recommends against revised Alcon deal (update)
Update 2:30pm: Adds STAAR Surgical comment. STAAR Surgical (STAA) dropped 5% after proxy adviser Glass Lewis recommended holders reject the revised $30.75 a share offer from Alcon (ALC). “We do not be...
2025-12-13 03:27
Broadwood Slams STAAR–Alcon Deal as Flawed and Unfair to Shareholders
Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood," "we," "us" or "our") today reacted to the proxy statement supplement filed by STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA) with
2025-12-11 20:12
